226 related articles for article (PubMed ID: 22942703)
1. Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice.
Jiang C; Huang H; Liu J; Wang Y; Lu Z; Xu Z
Int J Mol Sci; 2012; 13(7):8293-8307. PubMed ID: 22942703
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
3. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
4. [Effects of fasudil on bleomycin-induced pulmonary fibrosis in mice and on the biological behaviors in NIH3T3 mouse fibroblast cell line].
Jiang C; Huang H; Liu J; Wang Y; Zhao Y; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):671-6. PubMed ID: 25533689
[TBL] [Abstract][Full Text] [Related]
5. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
6. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
7. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
9. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
10. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
Xueyang D; Zhanqiang M; Chunhua M; Kun H
Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
[TBL] [Abstract][Full Text] [Related]
11. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
12. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
14. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W
J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
16. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Zhang L; Li Q; Liu Z; Liu W; Zhao M
Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
[TBL] [Abstract][Full Text] [Related]
19. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
[TBL] [Abstract][Full Text] [Related]
20. Fasudil inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose.
Gu L; Gao Q; Ni L; Wang M; Shen F
Chem Pharm Bull (Tokyo); 2013; 61(7):688-94. PubMed ID: 23812394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]